Cascade-Amplified Multidimensional Signal Integration Strategy Overcomes POCT Sensitivity-Accuracy Dilemma

Analytical Chemistry – ACS Publications International

Overview

A cascade-amplified multidimensional signal integration strategy using tetra-enzyme-mimicking Fe2O3/CoFe2O4 nanocubes has been proposed to overcome the sensitivity-accuracy dilemma in Point-of-Care Testing (POCT). This sensing mechanism relies on a cascade catalytic process involving target-induced hydrogel degradation and nanozyme-mediated signal amplification. This innovative tetramodal POCT strategy integrates colorimetric, photothermal, RGB, and pressure readouts, demonstrating high recovery and low Relative Standard Deviation (RSD) in real serum and urine samples.

In Depth

Background: Proliferation of POCT and the Sensitivity-Accuracy Dilemma

Point-of-Care Testing (POCT) plays an indispensable role in modern medicine by providing rapid diagnostic results and enabling immediate decision-making in clinical settings. However, POCT devices often face a challenge: their portability and simplicity can lead to inferior sensitivity and accuracy compared to laboratory-level detection systems. The ability to precisely detect trace biomarkers within complex biological samples (such as blood and urine) has posed a significant technical hurdle, requiring a breakthrough to achieve both high sensitivity and accuracy.

Technology of Cascade-Amplified Multidimensional Signal Integration Strategy

In this research, an innovative approach called the ‘cascade-amplified multidimensional signal integration strategy’ is proposed to overcome this sensitivity-accuracy dilemma. At the core of this strategy is the use of tetra-enzyme-mimicking Fe2O3/CoFe2O4 nanocubes. This relies on a two-step cascade catalytic process involving hydrogel degradation, induced by the presence of specific target molecules (e.g., pathogen DNA, cancer biomarkers), and signal amplification mediated by nanozymes (nanoparticles exhibiting enzymatic activity). This mechanism enables effective signal amplification even for minute target molecules, significantly improving the detection limit.

Tetramodal Detection and Clinical Significance

This innovative POCT strategy does not rely on a single detection method but integrates signals from four different modes (tetramodal): colorimetric (color change), photothermal (heat change), RGB values (color intensity), and pressure readings. By combining information from multiple signals, the reliability and accuracy of detection are dramatically enhanced, reducing the impact of false positives and interference. Experimental results using real serum and urine samples demonstrated high recovery rates and low Relative Standard Deviation (RSD) for various target molecules. This indicates that the technology can function with high reliability in actual clinical settings. This approach is expected to revolutionize POCT diagnostics for a wide range of diseases, including infectious diseases, cancer, and metabolic disorders, contributing significantly to public health and personalized medicine by providing rapid and accurate diagnoses in more locations.